Literature DB >> 1444678

Blue toe syndrome. Causes and management.

S T O'Keeffe1, B O Woods, D J Breslin, N P Tsapatsaris.   

Abstract

The sudden development of cyanotic lesions on the feet may be a result of atheroembolic disease or a number of medical conditions. A careful history and physical examination, basic laboratory tests, and noninvasive vascular assessment usually distinguish between medical and surgical causes and direct the choice of further investigations. Specific therapy is often available for medical conditions causing this syndrome. The management of atheroembolic disease is more controversial. In particular, further research is necessary to determine which patients need surgical intervention and which patients can be managed safely by medical therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444678

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Improvement in cholesterol emboli syndrome after iloprost therapy.

Authors:  Eran Elinav; Tova Chajek-Shaul; Mirella Stern
Journal:  BMJ       Date:  2002-02-02

2.  Blue toe syndrome, ischemic pain treated with digital block.

Authors:  Justin Belsky; Heidi Alvey; Alexis Bencze; Brooke Thompson; Stephanie Stokes-Buzzelli
Journal:  Intern Emerg Med       Date:  2015-01-21       Impact factor: 3.397

3.  Numerical simulation of blood flow in femoral perfusion: comparison between side-armed femoral artery perfusion and direct femoral artery perfusion.

Authors:  Shingo Kitamura; Minori Shirota; Wakako Fukuda; Takao Inamura; Ikuo Fukuda
Journal:  J Artif Organs       Date:  2016-06-02       Impact factor: 1.731

4.  Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Authors:  C Chandra Sekhar; Parveen Jindal; V Guru Karna; Manoj Aggarwala; Soma Sekhar
Journal:  Indian J Surg       Date:  2012-10-07       Impact factor: 0.656

5.  Rare Thrombotic Complications of COVID-19: A Case Series.

Authors:  Sruthi Vellanki; Anup Kumar Trikannad Ashwini Kumar; Ryan Stoffel; Sravya Vellanki; Zachary Nuffer
Journal:  Cureus       Date:  2022-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.